跳至主要内容
临床试验/NCT07091396
NCT07091396进行中(未招募)不适用

Enhancing Functional Recovery With Home-based Transcranial Direct Current Stimulation (tDCS) in Patients With Stroke, Neurodegeneration and Brain Tumors

Mayo Clinic1 个研究点 分布在 1 个国家目标入组 55 人开始时间: 2026年1月16日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
Mayo Clinic
入组人数
55
试验地点
1
主要终点
For patients with post-stroke cognitive impairment--Stricker Learning Span and Symbols Test

研究概览

简要总结

The purpose of this study is to assess the feasibility of home-based Transcranial Direct Current Stimulation (tDCS) combined with a home activity based therapy program in patients with stroke, brain tumors or neurodegenerative conditions and to assess the efficacy of home-based tDCS combined with a home activity-based therapy program as an intervention to treat cognitive-linguistic impairments related to stroke, brain tumors, or neurodegenerative conditions and improve quality of life.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • At least 3 months after ischemic/hemorrhagic/anoxic stroke or 3 months after completion of cranial radiation or cranial surgery for treatment of primary or metastatic intracranial tumors or neurodegenerative conditions include, but are not limited to, primary progressive aphasia, corticobasal syndrome, progressive supranuclear palsy, Parkinson's disease, and Alzheimer's disease dementia.
  • Expected survival >6 months
  • Functional impairment in the domains of language and/or cognition affecting quality of life determined by PI.
  • Have a legally authorized representative who is able to sign on their behalf in unable to consent for themselves (ex., individuals with aphasia).
  • Have a legally authorized representative who is able to sign on their behalf in unable to consent for themselves (ex., individuals with aphasia).

排除标准

  • Pregnancy
  • Contraindication to tDCS, including metallic implanted objects.
  • Medical instability or inability to cooperate during the study as assessed by the treating physician to participate in the study.
  • Individuals with epilepsy

研究组 & 干预措施

Home-Based Treatment: Active Stimulation, Then Sham Stimulation

Experimental

Subjects will first receive active tDCS, plus home activity based cognitive-linguistic therapy then they will cross over to the home-based sham treatment arm after a 4-8-week washout period.

干预措施: Soterix® tDCS - Home treatment (Device)

Home-Based Treatment: Sham Stimulation, Then Active Stimulation

Experimental

Subjects will first receive sham tDCS, plus home activity based cognitive-linguistic therapy then they will cross over to the home-based active treatment arm after a 4-8-week washout period.

干预措施: Soterix® tDCS - Home treatment (Device)

Home-Based Treatment: Sham Stimulation, Then Active Stimulation

Experimental

Subjects will first receive sham tDCS, plus home activity based cognitive-linguistic therapy then they will cross over to the home-based active treatment arm after a 4-8-week washout period.

干预措施: Cognitive-linguistic therapy (Behavioral)

Lab-Based Treatment: Active Stimulation, Then Sham Stimulation

Experimental

Subjects will be seen in person to first receive active tDCS for 12 sessions over 4 weeks, and cross-over to the lab-based sham treatment arm after an 8 week washout period.

干预措施: Soterix® tDCS - Lab treatment (Device)

Lab-Based Treatment: Sham Stimulation, Then Active Stimulation

Experimental

Subjects will be seen in person to first receive sham tDCS for 12 sessions over 4 weeks, and cross-over to the lab-based active treatment arm after an 8 week washout period.

干预措施: Soterix® tDCS - Lab treatment (Device)

Home-Based Treatment: Active Stimulation, Then Sham Stimulation

Experimental

Subjects will first receive active tDCS, plus home activity based cognitive-linguistic therapy then they will cross over to the home-based sham treatment arm after a 4-8-week washout period.

干预措施: Cognitive-linguistic therapy (Behavioral)

结局指标

主要结局

For patients with post-stroke cognitive impairment--Stricker Learning Span and Symbols Test

时间窗: Baseline, 3 weeks, 12 weeks, 15 weeks, 24 weeks

The Stricker Learning Span (SLS) is a computer-adaptive digital word list memory test specifically designed for remote assessment and self-administration on a web-based multi-device platform (Mayo Test Drive).

For patients with post-stroke language impairment--Mayo-developed web-based language

时间窗: Baseline, 3 weeks, 12 weeks, 15 weeks, 24 weeks

The exam includes a standard protocol including sentence and word repetition, standard reading passage, vowel prolongation, speech alternating motion rates , sequential motion rates, picture description, naming, and animal fluency

次要结局

  • Communicative Participation Item Bank(Baseline, 12 weeks, 24 weeks)
  • For patients with post-stroke language impairment--Western Aphasia Battery-Revised Bedside Version(Baseline, 12 weeks, 24 weeks)
  • Change in Visual Analogue Scale to Evaluate Fatigue Severity (VAS-F)(Baseline, 3 weeks, 12 weeks, 15 weeks, 24 weeks)
  • Change in Epworth Sleepiness Scale (ESS)(Baseline, 3 weeks, 12 weeks, 15 weeks, 24 weeks)
  • Karolinska Sleepiness Scale (KSS)(10 minutes before and after each treatment session)

研究者

发起方
Mayo Clinic
申办方类型
Other
责任方
Principal Investigator
主要研究者

Rene L. Utianski

Principal Investigator

Mayo Clinic

研究点 (1)

Loading locations...

相似试验